- Release Date: 10/12/24 12:31
- Summary: Interim data in Phase 2 study of SNT-5505 in myelofibrosis
- Price Sensitive: Yes
- Download Document 288.59KB
- Forums
- ASX - By Stock
- Ann: Interim data in Phase 2 study of SNT-5505 in myelofibrosis
SNT
syntara limited
Add to My Watchlist
16.4%
!
5.6¢

Ann: Interim data in Phase 2 study of SNT-5505 in myelofibrosis
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.6¢ |
Change
-0.011(16.4%) |
Mkt cap ! $92.60M |
Open | High | Low | Value | Volume |
6.7¢ | 6.7¢ | 5.6¢ | $470.5K | 7.877M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 177543 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 104873 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 177543 | 0.056 |
5 | 760854 | 0.055 |
2 | 225780 | 0.054 |
2 | 82852 | 0.053 |
2 | 153000 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 104873 | 5 |
0.059 | 70087 | 3 |
0.060 | 107942 | 4 |
0.061 | 139192 | 1 |
0.062 | 62319 | 1 |
Last trade - 15.16pm 16/06/2025 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |